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Abstract Alarin is a 25 amino acid peptide that belongs to
the galanin peptide family. It is derived from the galanin-
like peptide gene by a splice variant, which excludes exon
3. Alarin was first identified in gangliocytes of neuroblastic
tumors and later shown to have a vasoactive function in the
skin. Recently, alarin was demonstrated to stimulate food
intake as well as the hypothalamic–pituitary–gonadal axis
in rodents, suggesting that it might be a neuromodulatory
peptide in the brain. However, the individual neurons in the
central nervous system that express alarin have not been
identified. Here, we determined the distribution of alarin-
like immunoreactivity (alarin-LI) in the adult murine brain.
The specificity of the antibody against alarin was demon-
strated by the absence of labeling after pre-absorption of the
antiserum with synthetic alarin peptide and in transgenic
mouse brains lacking neurons expressing the GALP gene.
Alarin-LI was observed in different areas of the murine
brain. A high intensity of alarin-LI was detected in the
accessory olfactory bulb, the medial preoptic area, the
amygdala, different nuclei of the hypothalamus such as the
arcuate nucleus and the ventromedial hypothalamic nucleus,
the trigeminal complex, the locus coeruleus, the ventral
chochlear nucleus, the facial nucleus, and the epithelial layer
of the plexus choroideus. The distinct expression pattern of
alarin in the adult mouse brain suggests potential functions in
reproduction and metabolism.
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Introduction
Alternative posttranscriptional splicing plays an impor-
tant role in increasing the potential number of gene
products, resulting in proteomic diversity especially in
the central nervous system (Grabowski and Black 2001).
The splice variants of one gene are often differentially
regulated in a tissue- or developmental stage-specific
manner (Enigk and Maimone 1999). Therefore, detailed
information about the expression patterns of individual
splice variants is needed to investigate their putative
functions.
Galanin-like peptide (GALP) is an endogenous ligand of
the galanin receptors, and its amino acid residues 9–21
show complete sequence homology with galanin (Ohtaki et
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One particular splice variant excludes exon 3 and results in
a precursor protein that still harbors the signal sequence of
prepro-GALP and the first five amino acids of the mature
GALP peptide. Exclusion of exon 3 causes a frame shift
and leads to a 20 amino acid sequence that does not show
any homology to other proteins. Proteolytic processing of
this splice variant results in a novel 25 amino acid
neuropeptide, which was termed alarin because of its
N-terminal alanine and C-terminal serine residues (Santic
et al. 2006;L a n ge ta l .2007;S a n t i ce ta l .2007).
Alarin messenger RNA (mRNA) and peptide were
originally detected in human neuroblastic tumors (Santic
et al. 2006). Immunohistochemical analysis of tumor
samples showed that alarin-like immunoreactivity (alarin-
LI) is specifically found in gangliocytes of differentiated
neuroblastomas but not in undifferentiated tumor samples
(Santic et al. 2006). Alarin-LI was also detected in human
and murine skin (Santic et al. 2007). In the dermal vascular
system, alarin peptide is present in pericytes of microvas-
cular arterioles and venules and in layers of smooth muscle
cells in larger vessels, but not in endothelial cells. In vivo
experiments analyzing inflammatory edema formation in
mice revealed a dose-dependent inhibitory effect of alarin
on edema formation. This anti-edema effect is due to
alarin’s vasoconstrictor function (Santic et al. 2007).
Expression analysis revealed that alarin mRNA is also
present in the central nervous system (Santic et al. 2007).
Because GALP alters aspects of metabolism and reproduc-
tion, it is likely that alarin exerts similar effects via the
brain. Recently, it was shown that alarin stimulates feeding
behavior, increases body weight, and influences luteinizing
hormone (LH) secretion in rats. Intercerebroventricular
(i.c.v.) injection of alarin dose-dependently increased
acute food intake (Van Der Kolk et al. 2010; Boughton
et al. 2010). Furthermore, treatment with 1 nmol alarin i.c.
v. resulted in a significant increase in body weight after
24 h, an effect that was not seen at doses over 5 nmol (Van
Der Kolk et al. 2010; Boughton et al. 2010). Male sexual
behavior was not altered by alarin treatment in intact or
castrated rats, but luteinizing hormone secretion was
significantly increased in male rats (Van Der Kolk et al.
2010; Boughton et al. 2010). Furthermore, alarin is able to
stimulate the release of gonadotropin-releasing hormone
(GnRH) in both hypothalamic explants and a hypotha-
lamic cell line (Boughton et al. 2010). The effects of alarin
seem to be mediated by specific alarin receptors because
alarin lacks homology to galanin and is not able to
compete with galanin for galanin receptors (Santic et al.
2007; Boughton et al. 2010).
Finally, i.c.v. alarin injection increased fos expression
in the diencephalon and rhombencephalon of male rats.
Fos-immunoreactivity was detected in hypothalamic
nuclei of the paraventricular nucleus, the dorsomedial
nucleus, and the arcuate nucleus, but the greatest
induction of fos expression was observed in the solitary
tract, the nucleus prepositus, the dorsal vestibular nucleus,
and the olive nuclei (Van Der Kolk et al. 2010), indicating
that receptors recognizing alarin are present in these brain
areas.
To understand the neural circuitry underlying these
effects, one first needs to identify the alarin-expressing
neurons in the central nervous system. Here, we present the
distribution of alarin-LI in the adult mouse brain.
Materials and Methods
Alarin and GALP RT- and q-PCR
To extract RNA from different brain areas, mice were
euthanized, perfused with ice-cold ACSF (125 mM NaCl,
25 mM NaHCO3, 1.25 mM NaH2PO4, 2.5 mM KCl,
0.05 mM CaCl2, 6 mM MgCl2, 2.5 mM glucose, and
50 mM sucrose) and decapitated. The brain was quickly
removed, and coronal slices were cut on a Leica VT 1200S
vibratom.
For RT-PCR, different brain areas were punched out, and
RNA was extracted using Trizol (Invitrogen, Darmstadt,
Germany). For complementary DNA (cDNA) synthesis, a
Transcriptor High Fidelity cDNA Synthesis Kit (Roche,
Freiburg, Germany) was used following the manufacturer’s
instructions.
Because of low alarin/GALP transcript levels, a nested
PCRwas performed toanalyze alarin/GALPexpressioninthe
different brain areas. The first PCR amplification comprised
five cycles using TAQ DNA polymerase (Invitrogen, Darm-
stadt Germany) and primers 5′-cccacccttgtctctctccctaacctc-3′
(exon 1) and 5′-gtggcttcttccttgggaacattcttgt-3′ (exon 6) for
alarin/GALP and primers 5′-gaggagcaatgatcttgatcttcatggtg-3′
(exon 2/3) and 5′-ctaggcaccagggtgtgatggtgg-3′ (exon 5/6) for
α-actin (control). The second amplification comprised 40
cyclesusingnestedprimers5′-cctcattctcctcagaagctcacaaacc-3′
(exon 1) and 5′-ccttgggaacattcttgtccagtatgtgc-3′ (exon 6) for
alarin/GALP and primers 5′-gacccagatcatgtttgagaccttcaac-3′
(exon3/4)and5′-ccacaggattccatacccaagaaggaag-3′(exon4/5)
for α-actin. PCR products were separated by gel electropho-
resis and visualized with ethidium bromide. Successful
amplification yielded a 354-bp alarin, a 413-bp GALP, and a
462-bp α-actin amplicon (Fig. 1).
For quantitative RT-PCR (qPCR), the hypothalamic
area between bregma 0.8 and −2.0 was punched out, and
RNA was extracted using the RNeasy mini kit (Qiagen,
Hilden, Germany). For cDNA synthesis, superscript II
(Invitrogen) was used following the manufacturer’s
instructions. mRNA expression was analyzed using
J Mol Neurosci (2012) 46:18–32 19qPCR. cDNA was amplified using TaqMan Universal
PCR Master Mix with TaqMan Assay-on-Demand kits
for GALP (GALP, Mm00626135_m1) and TATA-box
binding protein (TBP) to measure reference gene levels
(TBP, Mm00446971_m1) (all from Applied Biosys-
tems). Each reaction was run in triplicate. qPCR was
p e r f o r m e do na nA B IP r i s m7 7 0 0s e q u e n c ed e t e c t o r
(Applied Biosystems). mRNA levels were calculated by
a comparative method Δ(ΔCt), where ΔCt=Ct (gene of
interest)−Ct(TBP) and Δ(ΔCt)=ΔCt (mutant)−mean ΔCt
(control). Results are expressed as PCR-cycle differ-
ences in relative gene expression with respect to control.
Recombineering and Generation of AGALP-Cre
Transgenic Mice
Bacterial artificial chromosome (BAC) RP23-404B17
(BACPAC Resources Center), comprising ∼66 kb of 5′
Fig. 1 Targeted ablation of
alarin and GALP neurons. a
Genetic strategy to express Cre
recombinase in alarin and GALP
neurons. b Transgenic mice
harboring the AGALP-Cre BAC
transgene were bred to the
ROSA26-DTA strain
(Brockschnieder et al. 2006).
In AGALP-Cre/R26-DTA mice,
DTA is expressed after Cre-
mediated excision of transcrip-
tional “STOP” signals flanked
by loxP sites, leading to death
of the Cre-expressing cell.
c Alarin/GALP mRNA levels
were reduced by ∼91% in adult
AGALP-Cre/R26-DTA animals
(n=2) compared to controls
(n=5). d Expression of GALP
and alarin mRNA in different
brain regions. RT-PCR analysis
on total RNA extracted from
different brain areas of wild-type
mice. Both GALP (405 bp) and
alarin (346 bp) mRNA are
detected in the olfactory bulb,
hypothalamus and brainstem,
but not in the cortex (OB olfac-
tory bulb, MPA medial preoptic
area, ARC arcuate nucleus, BS
brainstem, Cx cortex). Squares
in Fig. 4 indicate the regions
punched out for RNA isolation
20 J Mol Neurosci (2012) 46:18–32and ∼93 kb of 3′ flanking sequence of the GALP locus,
was modified by homologous recombination in bacteria
(recombineering) (Warming et al. 2005)( F i g .1). A
cDNA encoding Cre recombinase was PCR-amplified
from plasmid pKO-IRES-CRE (Wen et al. 2008)u s i n g
primers 5′-cccccaggcctatggccacaaccatgtcc-3′ and 5′-
cccccgccggctaatcgccatcttccagca-3′ and placed upstream of
an FRT-flanked neomycin resistance cassette in pBluescript
(Stratagene, Amsterdam, The Netherlands). We then gener-
ated two 200-bp GALP-homology arms using primers
GALP_start_f, 5′-ccgactgctggtccatagtgatcc-3′;G A L P _ s t a r t _ r ,
5′-gggggtcgaccctggagcggaaagagcacagcacacagc-3′; GALP_-
stop_f, 5′-ggggactagtccatacctcactcctccttcgtt-3′;G A L P _ -
stop_r, 5′-cactgggtcatctctggggtccc-3′, and placed them at
both ends of this cassette. The homology arms were chosen
such that the Cre cDNA would exactly replace the alarin/
GALP open reading frame from the ATG start to the stop
codon (Fig. 1a). The final recombineering vector was
linearized and electroporated into SW105 bacteria carrying
BAC clone RP23-404B17 (Warming et al. 2005).
Neomycin-resistant clones were screened by PCR and
restriction digest analysis for correct targeting. Finally, we
removed the neomycin cassette from recombinant BACs by
arabinose-induced expression of FLP/FRT recombinase
(Warming et al. 2005). The recombinant BAC was linearized
using a loxP site in the vector backbone, purified and
microinjected into pronuclei using standard methods.
Founder animals were backcrossed to C57BL/6J
animals to give alarin/GALP (AGALP)-Cre mice. For
genotyping, genomic DNA from tail biopsies was
prepared by proteinase K (Roche, Basel, Switzerland)
digestion and subsequent purification with DNA Isola-
tion Reagent for genomic DNA (AppliChem, Darmstadt,
Germany). Mice were genotyped by PCR using internal
Cre primers (5′-ggcgcggcaacaccattttt-3′ and 5′-
ccgggctgccacgaccaa-3′).
Mice
Animal care and experimental procedures were per-
formed in accordance with the guidelines established
by the animal welfare committee of the University of
Hamburg. Mice were kept under a standard light/dark
cycle with food and water ad libitum. AGALP-CRE
mice were kept in a mixed (129/SvJ and C57BL/6J)
background.
To systemically ablate alarin and GALP neurons, we
bred AGALP-Cre mice to the ROSA26-DTA (R26-DTA)
strain, which carries a targeted insertion of the diphtheria
toxin fragment A (DTA) gene in the ROSA26 locus
(Brockschnieder et al. 2006) (Fig. 1b). AGALP-Cre/R26-
DTA mice were born with expected Mendelian frequencies
and were viable.
Preparation of Brain Samples
Four adult C57BL/6J and four AGALP-Cre/R26-DTA mice
(3–4 months old) were anesthetized with ketamin/xylazine
(Bayer, Leverkusen, Germany) and perfused transcardially
with phosphate-buffered saline (PBS; 150 mM NaCl, 8 mM
Na2HPO4, 2 mM KH2PO4, pH 7.4) at 37°C, followed by
ice-cold 4% paraformaldehyde (Roth, Karlsruhe, Germany).
After 2hat4°C,brainswereremovedfromtheskullandpost-
fixed for 2 h at 4°C in 4% paraformaldehyde. Brains were
rinsed in PBS, transferred to 30% sucrose for 48 h, embedded
in tissue freezing medium OCT (Leica, Wetzlar, Germany)
and frozen in isopentane.
Generation of Anti-Alarin Antibody
Rabbit polyclonal antisera were custom-made (Neo MPS,
Strasbourg, France) using a synthetic murine alarin
peptide 6-24-Cys (SSPFPPRPTRAGRETQLLRC) (Santic
et al. 2007). Alarin 6–24 was coupled to the carrier
protein keyhole limpet hemocyanin via a C-terminal
cysteine residue. Immunization was carried out on days 0,
14, 28, and 56. Affinity purification of the antiserum was
carried out as described previously (Santic et al. 2006).
Briefly, immunogenic murine alarin 6–24 was coupled to a
HiTrap N-hydroxy-succinimide (NHS)-activated column
according to the manufacturer’s instructions (Amersham
Biosciences, Buckinghamshire, UK). The polyclonal anti-
alarin antiserum was loaded onto the column, and after
several washing steps, the purified antibody was eluted
and immediately neutralized using 20 mM Tris-HCl
(pH 9). Finally, the affinity-purified antibody was ali-
quoted and stored at −80°C until use. To exclude cross-
reactivity of the antibody to galanin or GALP, dot blot
analysis was performed. The affinity-purified antibody
was only able to detect synthetic murine alarin peptide
(NeoMPS, Strasbourg, France) but not galanin (Bachem,
Bubendorf, Switzerland) and GALP (Bachem, Bubendorf,
Switzerland).
Immunohistochemistry
For immunohistochemistry, 14-μm coronal brain sections
were cut on a cryostat, thaw-mounted on Superfrost
TM slides
(Menzel, Braunschweig, Germany), and stored at −80°C
until use. Sections were washed with PBS (58 mM
Na2HPO4,1 7m MN a H 2PO4, 68 mM NaCl, pH 7.4) and
incubated in 0.5% Triton X-100 in PBS for 10 min for
antigen retrieval. Immunostaining was performed according
to the protocol supplied with the DAKO ENVision+HRP
Detection System (DAKO, Glostrup, Denmark), with mod-
ifications. Endogenous peroxidases were quenched using a
peroxidase-blocking reagent for 5 min. After washing in
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0.5% Tween 20, pH 7.4), nonspecific binding sites were
blocked with 10% normal goat serum for 30 min at room
temperature. Afterwards, samples were incubated overnight
Fig. 2 Evaluation of the specificity of the rabbit-anti-alarin antibody.
Alarin-LI in the arcuate nucleus (a–c, e), the dorsal tuberomammilary
nucleus (a–c), and the facial nucleus (h). Preabsoption with 10 μM
GALP peptide (a) or galanin (c) does not abolish staining, whereas
preabsorption of the antibody with 10 μM alarin completely abolishes
alarin-LI (d, g). Alarin-LI is lacking in the arcuate (f) and the facial
nucleus (i) of transgenic AGALP-Cre/R26-DTA mice. Abbreviations
of nuclei are given in Table 1
22 J Mol Neurosci (2012) 46:18–32at 4°C with affinity-purified polyclonal anti-alarin antiserum
diluted 1:350 in DAKO Antibody Diluent (DAKO, Glostrup,
Denmark). For detection of the primary antibody, the slides
were incubated for 40 min at room temperature with
horseradish peroxidase-labeled polymer. Following another
washing step in PBS-T, alarin-LI was visualized using DAB
+solution of the DAKO ENVision System for 5 min. Finally,
the sections were dehydrated and permanently mounted
using Histokitt mounting medium (Assistent, Sondheim,
Germany). The specificity of the immunostaining was tested
by pre-absorbtion of the affinity purified anti-alarin antiseru
with 10 μM of the respective peptide, for 2–3ha t3 7 ° C .
Following centrifugation for 10 min at 13,000 rpm, serial
sections were incubated with the preabsorbed serum.
Image Preparation
Pictures were taken through a Zeiss microscope equipped
with AxioVision software (Zeiss, Jena, Germany). Images
were adjusted when necessary for brightness and contrast
using Adobe Photoshop (San Jose, CA, USA).
Results
Characterization of Anti-Alarin Antiserum
To systematically analyze the distribution of the novel
neuropeptide alarin throughout the mouse brain, we
performed immunohistochemistry using a polyclonal,
affinity-purified anti-alarin antiserum. The antiserum was
raised against alarin amino acid residues 6–24 because this
sequence is not shared with GALP. Therefore, the anti-
alarin antiserum does not show cross-reactivity for GALP
and galanin (Santic et al. 2007).
Antibodies are among the most frequently used tools in
basic research, but specificity and selectivity of epitope
binding must be carefully tested to avoid false positive
results (Lu and Bartfai 2009; Bordeaux et al. 2010). To
demonstrate specificity of the anti-alarin antiserum, we first
performed preabsorption experiments using C57BL/6J
(wild type) brains. Preabsorption with 10 μM synthetic
full-length alarin peptide completely inhibited antibody
binding in different brain areas (Fig. 2, d, g), whereas
preabsorption with either 10 μM murine GALP or galanin
had no effect on antibody binding (Fig. 2a, c).
Another possibility of testing the specificity of an
a n t i b o d yi st oa b l a t et h ec e l l s ,w h i c he x p r e s st h eg e n eo f
interest. To ablate alarin and GALP neurons, we bred
AGALP-Cre mice to the ROSA26-DTA (R26-DTA)
strain, which carries a targeted insertion of the diphtheria
toxin fragment A (DTA) gene in the ROSA26 locus
(Brockschnieder et al. 2006)( F i g .1b). The diphtheria
toxin A chain inhibits translation by catalyzing the ADP-
ribosylation of eukaryotic elongation factor 2, resulting in
cell death. Transcription of the R26-DTA allele terminates
prematurely in R26-DTA mice, due to a loxP-flanked
(floxed) strong transcriptional termination sequence. Cre-
mediated recombination triggers DTA expression and
leads to ablation of the Cre-expressing cell. Consistent
with this, GALP mRNA levels were reduced by ∼91% in
adult AGALP-Cre/R26-DTA animals (Fig. 1c). The
reproductive and metabolic phenotype of AGALP-Cre/
R26-DTA mice will be described elsewhere (Mayer et al.,
in preparation). As shown in Fig. 2, alarin-LI is present in
the hypothalamus and facial nucleus of wild-type but not
AGALP-Cre/R26-DTA mice. Taken together with the
preabsorption experiments, these results provide compel-
ling evidence for the specificity of the anti-alarin
antiserum.
Alarin and GALP Are Expressed in Various Brain Regions
To confirm our immunohistochemical results, we investi-
gated the expression of alarin and GALP mRNA in alarin-
LI positive and negative brain areas. To do this, we
performed RT-PCR analysis of total RNA extracted from
different brain areas of C57BL/6J mice (Fig. 1d). The
localization of the brain areas punched out is indicated in
Fig. 4. Alarin mRNAwas detected in the olfactory bulb, the
hypothalamus, and the brainstem, but not in alain-LI
negative parts of the cortex (Fig. 1d), suggesting a complex
pattern of alarin expression in the murine brain. GALP
peptide and mRNA are thought to be mainly expressed in
the arcuate nucleus of the hypothalamus (Jureus et al. 2001;
Santic et al. 2007). Consistent with this, we detected GALP
mRNA in the hypothalamus (Fig. 1c, d). Unexpectedly,
however, we also detected GALP mRNA in the olfactory
bulb and brainstem, indicating that GALP is expressed
outside of the hypothalamus.
Distribution of Alarin-LI in the Mouse Brain
The presence and intensity of alarin-LI are summarized in
Figs. 3 and 4 and Table 1. A detailed description of the
distribution is given below.
Telencephalon
Olfactory Bulb Alarin-LI was detected in both the main
and accessory olfactory system. In the main olfactory
bulb (MOB) the mitral cells as well as scattered single
cells in the glomerular layer displayed alarin-LI
(Figs. 3aa n d4a, b). Strong diffuse labeling was observed
in the accessory olfactory bulb (AOB) and the granule cell
layer of the AOB (Figs. 3ba n d4a, b). In comparison to
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the accessory olfactory system (Table 1).
Cortex Alarin-LI was observed in different areas of the
cerebral cortex. The prelimbic cortex and the piriform
cortex revealed alarin-positive neurons, and diffuse labeling
was detected in the olfactory tubercle and ventral tenia tecta
(Figs. 3e and 4c–j). In the cingulate cortex, pyramidal cells
in layers 3 and 5 were alarin-LI positive (Figs. 3f and 4c–f).
At the caudal end of the temporal lobe, alarin-LI staining
was detected in the entorhinal cortex and the subiculum
(Fig. 4l–n). Both areas contained alarin-LI-positive peri-
karya whereas diffuse labeling was observed in the ventral
but not in the dorsal hippocampus.
Basal Forebrain The vertical and horizontal parts of the
diagonal band of Broca were alarin-LI positive (Figs. 3c
and 4d, e). In the nucleus of the vertical limb of the
diagonal band, labeling of cell bodies and diffuse staining
was observed. However, in the nucleus of the horizontal
limb of the diagonal band, only weak alarin-LI of perikarya
was detected.
In the septal area, the lateral septal nucleus showed
alarin-LI-positive cells (Figs. 3d and 4e, f). Strong staining
was observed in the dorsal part of the nucleus, whereas in
the lateral part, only some cell bodies were alarin-LI
positive. Diffuse alarin-LI was detected in both parts of
the nucleus, parallel to the medial part of the lateral
ventricle.
Amygdala Along the ventral part of the hypothalamus and
the optic tract, diffuse alarin-LI was detected. It showed
high intensity in the area of the medial amygdala, becoming
weak again in the region of the cortical amygdaloid
nucleus. In the medial amygdala, alarin-LI-positive cell
bodies as well as diffuse labeling within the whole nucleus
occurred (Figs. 3l and 4h–j). In the cortical amygdaloid
nucleus, weak labeling of cells bodies was observed
(Figs. 4h–j).
Diencephalon
Alarin-LI was found throughout the diencephalon, but
labeling was strongest in the hypothalamic area.
Epithalamus In the medial habenular nucleus, strong but
diffuse alarin-LI was observed in and around cell bodies
(Figs. 3g and 4h–j). In contrast, no alarin-LI-positive cells
were detected in the lateral habenular nucleus.
Thalamus In the thalamic area, only the paraventricular
thalamic nucleus revealed alarin-LI (Figs. 3g and 4f–i).
Alarin-LI-positive cell bodies were detected adjacent to the
third ventricle. However, compared to the intensity of
labeling in the neighbouring medial habenular nucleus,
staining in the paraventricular thalamic nucleus appeared
weak (Figs. 3g and 4h, Table 1).
Hypothalamus Intense but diffuse alarin-LI was predomi-
nantly detected in the ventral part of the hypothalamus and
adjacent to the third ventricle. In the preoptic area, alarin-LI
was found in the median preoptic nucleus, the ventromedial
preoptic nucleus, the anteroventral periventricular nucleus,
the medial preoptic nucleus, and the magnocellular preoptic
nucleus (Figs. 3h and 4e, f). All nuclei were positive for
cell bodies, and the intensity of the labeling, except in the
magnocellular nucleus, was strong.
Caudal to the preoptic area, intense alarin-LI was
observed in the supraoptic nucleus, the suprachiasmatic
nucleus, the ventromedial hypothalamic nucleus, the arcu-
ate nucleus, the dorsal tuberomammilary nucleus, and the
dorsomedial hypothalamic nucleus (Figs. 3i, j and 4g–k).
Furthermore, diffuse labeling and some alarin-LI-positive
cells were seen in the periventricular hypothalamic
nucleus and the lateral hypothalamic area. In the para-
ventricular hypothalamic nucleus, some magnocellular
secretory cells were positive for alarin-LI as were some
small single cells in the optic tract (Fig. 3k).
Mesencephalon
Diffuse alarin-LI was observed in the interpeduncular
nucleus, showing high labeling intensity (Figs. 3m and
4l, m). Caudally, the pontine nuclei revealed strong alarin-
LI in medium-sized cells and diffuse staining around the
positive cells (Figs. 3o and 4m). Lateral to the pontine
nuclei, small single cells were detected in the middle
cerebellar peduncle, and labelling of medium intensity
was observed in the lateral lemniscus (Figs. 3n and 4n). In
the periaqueductal gray, weak alarin-LI of cell bodies was
observed along the aqueduct (Fig. 4l–n).
Pons
Beginning in the mesencephalon, the trigeminal tract
showed alarin-LI of different intensities (Table 1). Whereas
the sensory and motor root of the trigeminal nerve revealed
only some small alarin-positive cells, large multipolar
neurons were detected in the parvicellular motor trigeminal
nucleus, the principal sensory trigeminal nucleus, and the
motor trigeminal nucleus (Figs. 3p and 4n, o). Adjacent to
the fourth ventricle, the locus coeruleus, the dorsal
tegmental nucleus, and the parabranchial nucleus were all
alarin-LI positive (Figs. 3q and 4o). Whereas the dorsal
24 J Mol Neurosci (2012) 46:18–32tegmental nucleus and the parabranchial nucleus revealed
only weak labeling of cell bodies, the locus coeruleus
showed a higher intensity of alarin-LI.
Medulla Oblongata
In the dorsal medulla, alarin-LI was detected in the medial
vestibular nucleus, adjacent to the fourth ventricle (Fig. 4p).
On the ventral aspect, the oliviary complex and the nucleus
of the trapezoid body revealed alarin-LI-positive cells as
well as diffuse alarin-LI labeling (Figs. 3r and 4o). In the
trapezoid body and superior olive, only cell bodies were
alarin-LI positive, whereas in the perioliviary region, some
cell bodies and diffuse staining around the perikarya were
observed. In the lateral medulla, small cell bodies were
detected in the cochlear nucleus and spinal trigeminal tract
(Figs. 3s and 4o, p). Caudally, the facial nucleus showed
clear, alarin-LI-positive neurons of high labelling intensity
(Figs. 3t and 4p).
Circumventricular Organs and Ventricle
The epithelial layer of the choroid plexus of the lateral
ventricles revealed alarin-LI positve cells (Fig. 3g). Only
one of the circumventricular organs of the mouse showed
intense alarinergic innervation. In the vascular organ of the
lamina terminalis, strong diffuse alarin labelling was
detected (Figs. 3h and 4e). The other circumventricular
organs, except the median eminence, were alarin negative.
In the median eminence, weak diffuse alarinergic innerva-
tion, but no alarin-positive cell bodies, was detected.
Discussion
Here, we demonstrate for the first time that alarin-LI is
present in a variety of nuclei throughout the mouse brain.
Alarin is detected in similar brain regions as other members
of the galanin peptide family. For instance, in the
telencephalon, alarin-LI and galanin are both found in the
accessory olfactory bulb, the diagonal band of Broca, the
lateral septal nucleus, and in the medial amygdala (Perez et
al. 2001). Especially in the hypothalamic area, the
expression patterns of both peptides are quite similar (Perez
et al. 2001), raising the possibility that some neurons in
these regions might express more than one peptide of the
galanin peptide family. Immunoreactivity for both peptides
was detected in the medial preoptic nucleus, the periven-
tricular nucleus, the paraventricular nucleus, the supraoptic
nucleus, the dorsomedial nucleus, the premammilary
nucleus, the lateral hypothalamic area, the ventromedial
nucleus, and the arcuate nucleus (Perez et al. 2001).
However, in the thalamus, for example, alarin-LI was
present only in the paraventricular thalamic nucleus,
whereas galanin immunoreactivity was detected in a variety
of thalamic brain areas (Perez et al. 2001).
In the murine brain, the distribution of GALP mRNA
expression was detected in the arcuate nucleus of the
hypothalamus (Jureus et al. 2001). In situ hybridization,
however, did not differentiate between the GALP and alarin
splice variant. The alarin-LI in cell bodies of the arcuate
nucleus detected in the present study is consistent with the
mRNA expression of the GALP gene previously observed
in those same cells (Jureus et al. 2001). In the rat brain,
GALP mRNA expression and GALP-LI were also detected
in the arcuate nucleus, indicating the expression of both
splice variants in this region.
Localization of alarin-LI to the locus coeruleus of
mice has also been reported in the rat brain (Van Der
Kolk et al. 2010), indicating that there might be a similar
distribution of alarin in both species. Since the distribution
of GALP by immunohistochemistry has only been
investigated in the rat brain so far (Takatsu et al. 2001),
we can only compare the alarin-LI in mice to the
localization of GALP-LI in rats.
An overlap in the expression of the splice variants GALP
and alarin seems to be present in the medial preoptic area,
the lateral septal nucleus, the paraventricular hypothalamic
nucleus, the periventricular hypothalamic nucleus, and the
arcuate nucleus (Takatsu et al. 2001). Because there are
several regions that do not overlap between GALP and
alarin, the two peptides may also have distinct functions
and receptors.
So far, expression of GALP/alarin mRNA, detected by in
situ hybridization, has only been reported in the hypothal-
amus but not in other regions of the murine brain (Jureus et
al. 2001). We were also not able to detect GALP and alarin
mRNA in whole brain preparations by classical RT-PCR.
Although we have punched out alarin-LI positive regions
brain, we needed a nested RT-PCR to detect GALP and
alarin mRNA in these regions, indicating that the mRNA
expression levels of GALP and alarin are very low. Because
of the low expression levels of these two peptides, it will be
extremely difficult to distinguish their expression by in situ
hybridization with exon specific probes.
The diffuse staining of the extracellular matrix is a
phenomenon, which can only be observed in regions contain-
ing alarin-LI-positive cell bodies (Figs. 2 and 3). In brain
regions where no alarin-LI-positive cells are detected, no
diffuse background staining was observed. Therefore, we
hypothesize, that alarin is secreted from the cells into the
extracellular matrix, leading to a diffuse staining pattern of
the antibody. However, we also cannot exclude that there is
some diffuse unspecific background staining present.
Recently, i.c.v. injection of alarin into the lateral
ventricle of rats was shown to activate the expression of
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al. 2010). Because fos activation is a powerful tool to
identify neuronal activation (Kovacs 2008), it is most likely
that alarin-recognizing receptors are expressed in regions
where stimulation of fos expression occurs after alarin
treatment. In comparison to the localization of alarin-LI in
this study, fos immunoreactivty is detected in similar brain
regions. Alarin-LI and alarin-induced fos expression are
observed in the telencephalon in the medial preoptic
nucleus, the diagonal band of Broca, the paraventricular
hypothalamic nucleus, the lateral hypothalamus, the dorso-
medial nucleus, the lateral septal nucleus, and the para-
ventricular nucleus of the thalamus. In extra-diencephalic
structures, an overlap of alarin-LI and alarin-induced fos
expression seems to be present in the central gray, the locus
coeruleus, and in olive nuclei, whereas in raphe nuclei, the
nucleus prepositus, the dorsal vestibular nucleus, and the
dorsal motor nucleus of the vagus, only fos-immunoreactive
cells are detected. These data indicate that alarin activates
neurons in or adjacent to brain nuclei containing alarin-LI-
positive cells. The activation of fos also indicates the
presence of alarin receptors in these cells.
Olfaction
One key finding of this study is the detection of alarin-LI in
several brain areas dedicated to the sense of smell. The
olfactory system in rodents is important for reproduction,
consistent with a putative function of alarin in modulating
reproductive physiology. The rodent nose houses two distinct
sensory epithelia that are thought to be specialized in detecting
differentclassesofchemosensorycues(reviewedby(Tirindelli
et al. 2009). Alarin-LI was detected at different levels in both
the main and accessory olfactory system.
Alarin-LI in Brain Areas that Relay Odor Information
We detected alarin-LI in the MOB, which receives centrifugal
input from many different brain areas (Shipley et al. 2004).
Specifically, alarin-LI was observed in the mitral cells, which
are the first-order relay neurons receiving direct input from
olfactory sensory neurons in the main olfactory epithelium
(MOE). These data suggest a potential neuromodulatory
function of alarin in response to odor signals from the MOE.
In addition, alarin-LI was detected in the granule cell layer of
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Fig. 3 a, b. Olfactory system. Alarin-LI-positive cells were detected
in the mitral cell layer, the glomerular cell layer, and the accessory
olfactory bulb. c, d. Basal forebrain. The nuclei of the vertical and
horizontal limb of the diagonal band and the lateral septal nucleus
revealed alarin-LI. e, f. In the cortex alarin-LI-positive cells were
detected in the piriform and cingulate cortex. g In the thalamic area
and third ventricle, the choroid plexus and medial habenular nucleus
show strong alarin-LI and weak alarin-LI-positive cells in the
paraventricular thalamic nucleus. h–j Prepotic area. Intense alarin-
LI-positive cells and diffuse labeling are detected in the medial
preoptic area, the median preoptic nucleus, the vascular organ of the
lamina terminalis, the suprachiasmatic nucleus, the supraoptic nucleus,
and in the lateral hypothalamic area. Only single cells are detected in
the optic tract. k Alarin-LI in magnocellular secretory cells of the
paraventricular hypothalamic nucleus. l Intense alarin-LI of cells
detected in the medial amygdala and small single cells in the optic
tract. m Diffuse alarin-LI in the interpeduncular nucleus. n Small
single cells positive for alarin-LI indicated in the motor root of the
trigeminal nerve and middle cerebellar peduncle. In the lateral
lemniscus, cell bodies revealed to be positive for alarin-LI. o Strong
alarin-LI of medium-sized cells detected in pontine nuclei. p Alarin-
LI-positive neurons in the motor trigeminal nucleus, the motor root of
the trigeminal nerve, and the parvicellular motor trigeminal nucleus. q
In the pond, the locus coeruleus showed alarin-LI-positive neurons. r
Alarin-LI-positive neurons in the nucleus of the trapezoid body. s In
the chochlear nucleus, small single cells were alarin-LI positive. t
Alarin-LI-positive neurons in the facial nucleus. Abbreviations of
nuclei are given in Table 1. Abbreviations not included in Table 1: 3V
third ventricle, D3V third ventricle dorsal part, lfp longitudinal
fasciculus of the pons, scale bars=100 μm
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primary olfactory cortex (piriform cortex) and to the
olfactory amygdala (ACO), which impinges onto neuroen-
docrine target neurons in the hypothalamus such as GnRH
neurons (Boehm et al. 2005;Y o o ne ta l .2005). Strikingly,
alarin-LI was detected both in the piriform cortex and the
ACO, raising the possibility that alarin might be released in
response to certain odor cues.
Fig. 4 a–p Composite schematic drawings of coronal sections
showing the distribution of alarin-LI in murine brain. Dots indicate
alarin-LI-positive brain regions. Small dots indicate brain nuclei where
only small single cells are positive for alarin-LI. Abbreviations used in
the figure are included in Table 1. Squares indicate the areas punched
out for RT-PCR studies
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Intense alarin-LI was also found in the AOB, which
receives direct input from sensory neurons in the vomer-
onasal organ (VNO). The VNO is spatially segregated from
the MOE and is specialized in the detection of pheromones
(Halpern and Martinez-Marcos 2003). Information from the
AOB is transmitted to the vomeronasal amygdala, which is
specialized in relaying socially relevant signals from the
VNO to the hypothalamus (Halpern and Martinez-Marcos
2003). We found both alarin-LI-positive fibers and perikarya
in the medial amygdala, raising the possibility that alarin
might be released in response to certain pheromones. In
addition, alarin-LI is expressed in the central amygdaloid
nucleus, functioning as an output area of the amygdala and
connecting it to brainstem nuclei (including the locus
coeruleus) that mediate peripheral effects of fear responses.
Taken together, the distribution of alarin-LI indicates that the
peptide may be secreted in response to chemosensory cues
relevant for reproduction and metabolism.
Fig. 4 (continued)
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Region Abbreviation Intensity
a
Accessory olfactory bulb AOB +++
Anteroventral periventicular nucleus AVPe +++
Arcuate nucleus of the hypothalamus Arc +++
Cingulate cortex Cg +
Cochlear nucleus VC ++
Cortical amygdaloid nucleus Co +
Dorsal tuberomammilary nucleus DTM ++
Dorsal tegmental nucleus DTg +
Dorsomedial hypothalamic nucleus DMH +++
Entorhinal cortex Ent +
Facial nucleus 7N ++
Glomerular layer of the olfactory bulb Gl ++
Granule cell layer of the accessory olfactory bulb GlA +++
Interpeduncular nucleus IP ++
Lateral hypothalamic area LA +
Lateral lemniscus ll ++
Lateral septal nucleus LS ++
Locus coeruleus LC ++
Magnocellular preoptic nucleus MCPO +
Medial amygdala MeA ++
Medial habenular nucleus MHb ++
Medial preoptic area MPA +++
Medial preoptic nucleus MPO ++
Medial vestibular nucleus MVe ++
Median preoptic nucleus MnPO +++
Middle cerebellar peduncle mcp +
Mitral cell layer of the olfactory bulb Mi ++
Motor root of the trigeminal nerve m5 +
Motor trigeminal nucleus Mo5 ++
Nucleus of the horizontal limb of the diagonal band HDB +
Nucleus of the trapezoid body Tz ++
Nucleus of the vertical limb of the diagonal band VDB ++
Olfactory tubercle Tu +
Optic tract opt +
Parabranchial nucleus PB +
Paraventricular hypothalamic nucleus Pa +
Paraventricular thalamic nucleus PV +
Parvicellular motor trigeminal nucleus PC5 +
Periaqueductal gray PAG +−
Perioliviary region PO +
Periventricular hypothalamic nucleus Pe +
Piriform cortex Pir +
Pontine nuclei Pn +++
Prelimbic cortex PrL ++
Premammillary nucleus, ventral part PMV +++
Principal sensory trigeminal nucleus Pr5 ++
Sensory root of the trigeminal nerve s5 +
Spinal trigeminal tract Sp5 +
Subiculum S +
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Alarin impinges on the hypothalamic–pituitary–gonadal
(hpg) axis and influences LH secretion (Van Der Kolk et
al. 2010; Boughton et al. 2010). Our novel data may
illuminate a neural substrate potentially underlying these
effects. LH secretion is controlled by a small subset of
hypothalamic neurons that produce and secrete GnRH.
GnRH neurons mediate central control of reproductive
physiology in vertebrates and communicate with a large
number of neurons in other parts of the brain to integrate a
variety of signals important for reproduction (Boehm et al.
2005; Yoon et al. 2005; Herbison 2006). GnRH neurons
receive information from at least 10,000 neurons in 12
different brain areas (Boehm et al. 2005). Interestingly,
some of these brain areas (e.g., in the hypothalamus and
thalamus) with neurons upstream of GnRH neurons display
alarin-LI, suggesting that alarin effects on GnRH neurons
might be direct. Consistent with this, alarin was shown to
stimulate GnRH release in both hypothalamic explants and
a hypothalamic cell line (Boughton et al. 2010). Because
alarin lacks homology to galanin and does not bind to
galanin receptors (Santic et al. 2007; Boughton et al. 2010),
alarin effects on LH secretion are probably mediated via an
unknown receptor. Future studies will need to identify the
alarin receptor and determine whether it is expressed in
GnRH neurons.
Metabolism
Alarin injection into the brain stimulates feeding behavior
and increases body weight (Van Der Kolk et al. 2010;
Boughton et al. 2010). The feeding center in the hypothal-
amus resides in the arcuate nucleus (Cone 2005; Horvath
2005). Many different neuropeptides that influence feeding
behavior and body weight are expressed by arcuate nucleus
neurons, including proopiomelanocortin (POMC), α-
melanocyte-stimulating hormone (α-MSH), neuropeptide
Y (NPY), and agouti-related protein (AgRP) (Cone 2005;
Horvath 2005). A well-established model neural circuit
underlying feeding behavior comprises NPY/AgRP and
POMC/α-MSH neurons: Activation of POMC neurons by
leptin triggers the release of α-MSH from POMC axon
terminals and leads to suppressed food intake and increased
energy expenditure. Simultaneously, leptin suppresses the
activity of arcuate nucleus NPY/ AgRP neurons, which
otherwise would antagonize the α-MSH effect through the
release of AgRP (Horvath 2005). Consistent with alarin’s
role in influencing metabolism, alarin-LI was detected in
the arcuate nucleus. This is also where GALP is expressed
(see above). Only a subset of arcuate nucleus neurons
displays alarin-LI. It is not known whether the same or
different sets of neurons co-express alarin and GALP. It is
also not known whether alarin is expressed in POMC/α-
MSH or NPY/AgRP neurons.
In conclusion, the present study clearly establishes alarin
as a multifunctional neuropeptide. As is the rule for
neuropeptides, alarin is expressed in discrete areas of the
brain. Because these loci are known to regulate metabolism,
reproduction, and behaviour, alarin is poised to be added to
the list of multifunctional regulatory peptides.
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Table 1 (continued)
Region Abbreviation Intensity
a
Superior olive SPO ++
Suprachiasmatic nucleus SCh +++
Supraoptic nucleus SO +++
Vascular organ of the lamina terminalis VOLT +++
Ventral hippocampus VH +
Ventromedial hypothalamic nucleus VMH +++
Ventromedial preoptic nucleus VMPO +++
aBrain regions showed strong (+++), medium (++) or weak (+) intensity of alarin-LI
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